The FDA recommendations are more expansive than safeguards announced earlier this month by the American Red Cross. Medscape Medical News
Category: News
CMS Releases Core Quality Measures
(MedPage Today) — Aimed at reducing administrative burdens on physicians
Ocular Therapeutix™ Announces Phase 3 Clinical Development Plan for OTX-TP, an Innovative Therapy for Glaucoma and Ocular Hypertension
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced the Phase 3 clinical d…
CORRECTING and REPLACING MEDIA ALERT: CSIRO to Host Silicon Valley Innovation Summit & Showcase
PALO ALTO, Calif.–(BUSINESS WIRE)–Please replace the release dated February 11, 2016 with the following corrected version due to multiple revisions. The corrected release reads: MEDIA ALERT: CSIRO TO HOST SILICON VALLEY INNOVATION SUMMIT & SHOWCASE Australia’s Scientific and Research Organization Will Highlight New Breakthroughs and Outline Roadmap for Collaboration with Silicon Valley Technology Community CSIRO, the scientific and research organization for Australia responsible for the b
Global Prescription/Rx Sunglass Market Worth USD 3.76 Billion by 2022 – Analysis, Technologies & Forecast Report 2016-2022 – Key Vendors: Bausch & Lomb, Carl Zeiss, Charmant Group – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/g5lftv/prescriptionrx) has announced the addition of the “Prescription/Rx Sunglass Market Analysis By Lens Material (Glass, CR-39, Polycarbonate, Polyurethane) An…
Signs of AMD Regress With Statin Treatment
High-risk signs of dry age-related macular degeneration (AMD) regress with intensive statin treatment, according to results from a pilot interventional study. Reuters Health Information
Scientists discover genetic changes linked to a major risk factor for blinding trachoma
Another clue to the workings of trachoma – the world’s leading infectious cause of blindness – has been revealed in a new study published in BMC Infectious Diseases.
Five Healthcare-Related Cases Scalia Left Behind
(MedPage Today) — Abortion restrictions, contraceptive coverage mandate are among cases yet to be decided
IRIDEX’s Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma
IRIDEX Corporation, a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that it has received its CE Mark to commercialize across Europe its first laser system in its class designed s…
Second Sight Announces Publication of Positive Results in 3-Year FLORA Study of the Argus II
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (“Second Sight” or “the Company”) (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced the publication of a positive 3-year FLORA study in the Australian journal Clinical And Experimental Optometry for the Argus® II Retinal Prosthesis System (“Argus II”). The Functional Low-Vision Observer Rated Assessment (FLORA), a multi-part
Statins May Aid in Dry Macular Degeneration
(MedPage Today) — Signs of AMD regressed in small trial
Evidence-Based Medicine Loses a Round in Federal Court
(MedPage Today) — Federal courts have been too kind to off-label marketing, says Caroline Poplin, MD, JD
Glaukos Corporation to Release Fourth Quarter & Full Year 2015 Financial Results after Market Close on March 1
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release fourth quarter and full year 2015 financial results after the market close on Tuesday, March 1, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m.
PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment 2015-2024 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/hc7wft/pharmapoint_dry) has announced the addition of the “PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment to 2024” report to their off…
CMS Releases Final Rule on Medicare Overpayments
(MedPage Today) — Docs will only have to look back 6 years, not 10
Biggest Ever Infectious Disease Survey to Speed End of Trachoma
The scale and quality of the survey mean trachoma, an extremely painful disease which causes blindness, could be eliminated by 2020. Reuters Health Information
Higher intake of food-based vitamin D during pregnancy linked to reduced risk of allergies in children
Higher intake of foods containing vitamin D during pregnancy – but not supplemental vitamin D intake – was associated with reduced risk of development of allergies in children, according to a study led by an investigator from the Icahn School of Medici…
Corneal Inlay Implantation Complicated by Keratitis
The authors report on several cases of infectious keratitis after corneal inlay implantation for presbyopia — and discuss prevention and management strategies for this complication. The British Journal of Ophthalmology
A 35-Year-Old Man With Long-standing Decreased Vision
A 35-year-old man who never considered his vision to be normal is experiencing progressively decreased vision. What is the most likely diagnosis? Medscape Ophthalmology
Lower Oxygen Target Ups Death, Disability in Preemies
Pooled results from UK and Australian trials found that a lower oxygen saturation target was linked to increased risk for death or disability at 2 years’ corrected age in premature infants. Medscape Medical News